User: prashantiyengar Topic: IP
Category: patents :: india
Last updated: Feb 07 2016 12:42 IST RSS 2.0
 
1 to 20 of 5,640    
The pill that costs $9,000 in US sells for $70 in India 7.2.2016 ET: Pharma
Typically, the price of many expensive patented drugs in European countries like France, Spain or the UK is half of what these cost in the US.
Also found in: [+]
Nirmala Sitharaman asks pharmaceutical industry to reduce dependence on API imports 5.2.2016 DNA: Recent Columns
Commerce and Industry Minister Nirmala Sitharaman on Friday raised serious concerns over increasing imports of Active Pharmaceutical Ingredients (APIs) and asked the experts and industry to work in the direction to reduce the dependence on imports. "When we are setting up pharmaceutical and biotechnology hubs... the dependence on imported APIs worries me a lot," she said at the Global Biotechnology Summit. Sitharaman said as India is a global hub of generic medicines and biotechnology centres, industry, academia and experts should work in reducing the increasing imports. India is hugely dependent on China for import of the APIs, which are the raw materials for medicines. Indian firms imported APIs and intermediates worth nearly $3 billion (nearly Rs 20,343 crore) in 2010-11 with China alone accounting for $1.88 billion (nearly Rs 12,748.28 crore).  The minister said both developing and developed countries are dependent on India for affordable generic medicines. Further, the Commerce Ministry is ...
Also found in: [+]
Dependence on imported APIs is worrisome: Nirmala Sitharaman 5.2.2016 ET: Foreign Trade
Commerce and industry Minister Nirmala Sitharaman today raised serious concerns over increasing imports of active pharmaceutical ingredients.
Also found in: [+]
China seeks food security with $43 billion bid for Syngenta 3.2.2016 TOI: Intl Business
China made its boldest overseas takeover move when state-owned ChemChina agreed a $43 billion bid for Swiss seeds and pesticides group Syngenta on Wednesday, aiming to improve domestic food production. This also marks a setback for US firm Monsanto, which failed to buy Syngenta last year.
Also found in: [+]
Union Minister of Science & Technology and Earth Sciences Dr. HARSH Vardhan appeals to the scientific community to synergize professionally 3.2.2016 Govt of india: PIB
Union Minister of Science & Technology and Earth Sciences Dr. HARSH Vardhan appeals to the scientific community to synergize professionally

Also found in: [+]
Indian firm developing vaccine for Zika virus 3.2.2016 The Assam Tribune
Indian firm developing vaccine for Zika virus
Also found in: [+]
Indian company claims breakthrough in developing vaccine to fight Zika 3.2.2016 TOI: India
"We believe we have an early mover advantage in developing the Zikavac and we are probably the first in the world to file for global patent for Zika vaccine candidates," said Krishna Ella, CMD Bharat ...
Also found in: [+]
India may lead the race to bring out vaccine for Zika virus: Report 3.2.2016 DNA: Money
Amid the scare over the mosquito-borne Zika virus, which has now been declared an international public health emergency by the World Health Organization (WHO), scientists in India have claimed that they have developed the world's first vaccine for it. According to NDTV, scientists at a Hyderabad lab said they have developed not one, but two vaccines, using a live Zika virus imported officially. The virus, linked to severe birth defects in thousands of babies in Brazil, is spreading rapidly in the Americas, and WHO officials have expressed concern that it could hit Africa and Asia as well. "On Zika, we are probably the first vaccine company in the world to file a vaccine candidate patent about nine months ago," Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech Ltd told NDTV.  Dr. Soumya Swaminathan, Director General of Indian Council of Medical Research (ICMR ) said that they would see the feasibility of taking it forward and that the vaccine could be a a good example of a 'Make in India' ...
Also found in: [+]
Dr. Harsh Vardhan inaugurates the “MAGIC” process lab at CSIR-National Chemical Laboratory, Pune 3.2.2016 Govt of india: PIB
The Union Minister for Science & Technology & Earth Sciences, Dr Harsh Vardhan, inaugurated a unique MAGIC [Modular, Agile, Intensified & Continuous] Process Lab at CSIR-National Chemical Laboratory (CSIR-NCL) Pune last evening. While inaugurating the facility he announced that “The MAGIC processes and plants will bring about a paradigm shift in the way in which India’s Fine and Specialty Chemicals industry will operate in the future.
Also found in: [+]
Power, water supplies to Cong MP's bungalow cut 3.2.2016 TOI: India
Power and water supply connections were snapped to the bungalow occupied by Congress MP Adhir Ranjan Chowdhury on Tuesday as officials from the urban development ministry started the physical eviction ...
Also found in: [+]
RBI to create enabling framework for growth of startups 2.2.2016 ET: Policy
A liberalised patent regime is being brought to help start-up businesses register patents, for which the fee will be slashed by 80 per cent.
Also found in: [+]
Sun hopes cut-price generic Gleevec will win third of U.S. market 2.2.2016 Sify Finance
ZURICH (Reuters) - India's Sun Pharma launched a generic version of Novartis's leukaemia drug Gleevec on Monday in the United States and hopes to poach a third of sales in six
Also found in: [+]
Sensible eating can keep India fit: GSK CEO 28.1.2016 TOI: India Business
The best way for any country to ensure the well-being of its people is to see that they follow an active lifestyle, eat sensibly and generally follow the precepts of prevention.
Also found in: [+]
SC agrees to hear Cipla’s plea against La Roche 28.1.2016 TOI: India Business
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging the Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche’s patent over lung cancer drug Erlotinib.
Also found in: [+]
ET GBS: Active lifestyle, sensible eating can keep India fit, says GlaxoSmithKline CEO Andrew Witty 28.1.2016 ET: Policy
The best way for any country to ensure the well-being of its people is to see that they follow an active lifestyle, eat sensibly and generally follow the precepts of prevention.
Also found in: [+]
Supreme Court agrees to hear Cipla’s plea against La Roche 27.1.2016 TOI: India
The Supreme Court on Wednesday admitted a plea of generic drug manufacturer Cipla Ltd challenging Delhi high court order holding it guilty of infringing Swiss pharma company Hoffmann-La Roche. Roche’s patent over lung cancer drug ...
Also found in: [+]
Big Pharma’s worst nightmare | Sarah Boseley 26.1.2016 The Guardian -- Front Page
Jamie Love has spent years battling global drug companies, unshakable in his belief that even the world’s poorest people should have access to life-saving medicines. Is it time that our own government listened to him? On a hot August afternoon in 2000, four Americans arrived for a secret meeting at the central London penthouse flat of an Indian billionaire drug manufacturer named Yusuf Hamied. A sixth person would join them there, a French employee of the World Health Organisation, who was flying in from Geneva, having told his colleagues he was taking leave. Hamied took his guests into the dining room on the seventh floor. The room featured a view of the private gardens of Gloucester Square, Bayswater, for which only the residents possess a key. The six men sat round a glass dining table overlooked by a painting of galloping horses by a Mumbai artist (Hamied has racehorses stabled in three cities). The discussion, which went on all afternoon and through dinner that evening at the Bombay Palace ...
Also found in: [+]
EU trademark norms may hit Indian drug exports 26.1.2016 TOI: India Business
Faced with seizures of crucial drug consignments originating from the country, India had earlier raised the issue with the WTO dispute settlement mechanism against the EU.
Also found in: [+]
India rejects licence plea for AstraZeneca's anti-diabetic drug 20.1.2016 ET: Pharma
The Indian patent office has rejected Hyderabad-based Lee Pharma's application for a compulsory licence on AstraZeneca's anti-diabetic medicine saxagliptin.
Also found in: [+]
India rejects compulsory license application of Lee Pharma against AstraZeneca’s Saxagliptin 20.1.2016 ET: Pharma
The Indian Patent Office has rejected the application of Lee Pharma for a compulsory license on AstraZeneca’s anti-diabetes drug saxagliptin branded as Onglyza.
Also found in: [+]
1 to 20 of 5,640